Pembrolizumab plus Chemotherapy for Synchronous Multiple Primary Esophageal and Gingival Squamous Cell Carcinomas.
A patient with simultaneous squamous cell cancers of the esophagus and gingiva received pembrolizumab combined with chemotherapy, achieving significant tumour responses with good tolerance and functional improvement.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceThe Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall